代俊婷, 孟志云, 朱晓霞, 甘慧, 顾若兰, 杨波, 余丽英, 窦桂芳. HPLC-MS/MS法同时测定大鼠血浆中优格列汀及其代谢产物J. 药学学报, 2014,49(7): 1044-1048.
引用本文: 代俊婷, 孟志云, 朱晓霞, 甘慧, 顾若兰, 杨波, 余丽英, 窦桂芳. HPLC-MS/MS法同时测定大鼠血浆中优格列汀及其代谢产物J. 药学学报, 2014,49(7): 1044-1048.
DAI Jun-ting, MENG Zhi-yun, ZHU Xiao-xia, GAN Hui, GU Ruo-lan, YANG Bo, YU Li-ying, DOU Gui-fang. Determination of yogliptin and its metabolite in Wistar rat plasma by liquid chromatography-tandem mass spectrometryJ. Acta Pharmaceutica Sinica, 2014,49(7): 1044-1048.
Citation: DAI Jun-ting, MENG Zhi-yun, ZHU Xiao-xia, GAN Hui, GU Ruo-lan, YANG Bo, YU Li-ying, DOU Gui-fang. Determination of yogliptin and its metabolite in Wistar rat plasma by liquid chromatography-tandem mass spectrometryJ. Acta Pharmaceutica Sinica, 2014,49(7): 1044-1048.

HPLC-MS/MS法同时测定大鼠血浆中优格列汀及其代谢产物

Determination of yogliptin and its metabolite in Wistar rat plasma by liquid chromatography-tandem mass spectrometry

  • 摘要: 建立快速灵敏、简便的液相色谱-串联质谱 (HPLC-MS/MS) 法同时测定Wistar大鼠血浆中优格列汀及其代谢产物M1(R)-8-(3-羟基哌啶-1-基)-7-(2-丁炔-1-基)-1-((5-氟苯并d噻唑-2-基)甲基)-3-甲基-1H-嘌呤-2,6 (3H,7H)-二酮,并研究优格列汀、M1在Wistar大鼠体内的药代动力学特征。优格列汀、M1分别以利格列汀和地塞米松为内标,血浆样品经乙腈沉淀蛋白后,以10% 乙腈水溶液 (含4 mmol·L-1醋酸铵,0.1% 甲酸) -90% 甲醇水溶液 (含4 mmol·L-1醋酸铵,0.1% 甲酸) 为流动相,通过Grace Altima HP C18柱 (2.1 mm × 50 mm,5 μm) 梯度洗脱,色谱运行时间为4.4 min。采用电喷雾电离源,以多反应监测方式进行正离子检测。优格列汀、M1的标准曲线的线性范围均为0.5~500 ng·mL-1,定量下限均为0.5 ng·mL-1,日内和日间精密度 (RSD) 均小于14%。应用此法研究了Wistar大鼠口服灌胃给予优格列汀混悬液 (27 mg·kg-1) 后的药动学特点。本方法简便、准确、专属性强,适用于优格列汀和M1在Wistar大鼠体内的药代动力学研究。

     

    Abstract: A rapid, sensitive and simple liquid chromatography-tandem mass spectrometric (LC-MS/MS) method was developed for the simultaneous determination of yogliptin and its metabolite in Wistar rat plasma. Linagliptin and dexamethasone were chosen as the internal standards of yogliptin and its metabolite, (R)-8-(3- hydroxypiperidine-1-yl)-7-(but-2-yn-1-yl)-1-((5-fluorobenzodthiazol-2-yl)methyl)-3-methyl-1H-purine-2, 6 (3H, 7H)-dione, respectively. After a simple protein precipitation using acetonitrile as the precipitating solvent, both analytes and ISs were separated on a Grace Altima HP C18 column (2.1 mm × 50 mm, 5 μm) with gradient elution using methanol (containing 0.1% formic acid, 4 mmol·L-1 ammonium acetate) - 0.1% formic acid (containing 4 mmol·L-1 ammonium acetate) as the mobile phase. A chromatographic total run time of 4.4 min was achieved. Mass spectrometric detection was conducted with electrospray ionization under positive-ion and multiple-reaction monitoring modes. Linear calibration curves for yogliptin and its metabolite were over the concentration range of 0.5 to 500 ng·mL-1 with a lower limit of quantification of 0.5 ng·mL-1. The intra- and inter- assay precisions were all below 14%, the accuracies were all in standard ranges. The method was used to determine the concentration of yogliptin and M1 in Wistar rat plasma after a single oral administration of yogliptin (27 mg·kg-1). The method was proved to be selective, sensitive and suitable for pharmacokinetic study of yogliptin and M1 in Wistar rat plasma.

     

/

返回文章
返回